ESR1 and breast cancer: MDA-MB-231 human breast cancer cells correspond to a poorly differentiated triple negative breast cancer (TNBC) cell line that does not express the progesterone or estrogen receptors or the receptor tyrosine-protein kinase erbB-2 (ERBB2/Her2).